Gatifloxa-polysebacic anhydride local delivery system for prevention of osteomyelitis in rabbits

doi:10.3969/j.issn.2095-4344.2014.21.014

Abstract

Abstract:

BACKGROUND: Polyanhydride materials characterized as surface corrosion resistance, biodegradability and adjustable release rate have been used as drug delivery materials for the body, but the application of polysebacic anhydride delivery system has been rarely reported.
OBJECTIVE: To study the role of gatifloxa-polysebacic anhydride local delivery system in the prevention of osteomyelitis in rabbits.
METHODS: According to Norden method, we made Staphylococcus aureus-induced osteomyelitis models in the femur of 30 rabbits. There were three groups in the study, 10 rats in each group. Gatifloxa-polysebacic anhydride local delivery system and gatifloxa were respectively used in comparison with model group. After modeling, general observation, anatomical observation, X-ray examination, bone culture and bacteria counting, and histological examination were performed.
RESULTS AND CONCLUSION: After 8 weeks, animals in the model group presented with poor appetite, rough fur, and weight loss. Among these 10 rabbits, 3 rabbits died within 3 weeks, and another 7 rabbits appeared to have severe periosteal reactions on the X-ray films, that is, abscess formation shown in the anatomical examination and visible manifestation of osteomyelitis through bone culture and histological examination. In the gatifloxa group, two rabbits died within 3 weeks, abscess formation was found in four rabbits, and periosteal reactions were mild without bone sequestration. Six of 10 rabbits in the gatifloxa appeared to have manifestation of osteomyelitis. In the delivery system group, the animals had a good general state of health and no abnormality
was found in the anatomical examination, X-ray examination, bone culture and bacteria count, and histological examination. These findings indicate that the gatifloxa-polysebacic anhydride local sustained release preparation could effectively prevent osteomyelitis.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

全文链接：

Key words: osteomyelitis, biocompatible materials, infection, femur

CLC Number:

R318

Lu Feng, Yan Xue-zheng, Ma Shu-you, Zhang Hong-tu. Gatifloxa-polysebacic anhydride local delivery system for prevention of osteomyelitis in rabbits[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(21): 3355-3360.

Figures/Tables 5

References

[1]Domb AJ, Rock M, Perkin C. Excretion of a radiolabeled anticancer biodegradable polymeric implant from the rabbit brain. Biomaterials. 1995;16(14):1069-1072.
[2]Norden CW, Shafferm M. Experimental osteomyelitis due to Staphylococcus aureus or Pseudomonas aeruginosa: a radiographic-pathological correlative analysis. Br J Exp Pathol. 1980;61(4):451-460.
[3]Laurence ED, Charle H. Gentamicin-loaded plaster of Paris as a treatment of experimental osteomyelitis in rabbits. Clin Orthop Relat Res. 1987;(219):278-282.
[4]鲁锋,张鸿图.马术友.加替沙星-聚癸二酸酐局部缓释系统的体内释药特性[J].中国组织工程研究,2013,17(29):5351-5356.
[5]鲁锋,张鸿图,马术友.加替沙星-聚癸二酸酐局部缓释系统的生物相容性[J].中国组织工程研究,2013,17(25):4623-4628.
[6]Ostermann PA, Seligson D, Henry SL. Local antibiotic therapy for severe open fractures. A review of 1085 consecutive cases. J Bone Joint Surg Br. 1995;77(1):93-97.
[7]Grace EJ, Bryoson V. Modern treatment of chronic osteomyelitis with topical detergent antibiotic therapy. Surg Gynecol Obstet. 1950;91(3):333-342.
[8]Perry CR, Kitterbusch JK, Rice SH, et al. Antibiotics delivered by an implantable drug pump; a new application for treating osteomyelitis. Am J Med. 1986;80(6B):222-227.
[9]陈爱民,侯春林.几丁糖庆大霉素药物释放系统的研制及体外释放实验[J].中华骨科杂志,1997;17(9):592.
[10]Kahn DS, Pritzker KP. The pathophysiology of bone infection. Clin Orthop Relat Res.1973;8(96):12-19.
[11]Mayberry-Carson KJ, Tober-Meyer B, Smith JK, et al. Bacterial adher ence and glycocalyx formation in osteomyelitis experimentally induced with staphlococcus aureus. Infect Immun. 1984;43(3):825-833.
[12]Nickel JC, Ruseska I, Wright JB, et al. Tobramycin resistance of pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother. 1985; 27(4):619-624.
[13]Taylor AR, Maudsley RH. Instillation-suction technique in chronic osteomyelitis. J Bone Joint Surg Br. 1970;52(1): 88-92.
[14]Wahlig H, Dingledein E, Bergmann R, et al. The release of gentamicin from polymethylmethacrylate beads-an experimental and pharmacokinetic study. J Bone Joint Surg Br. 1978;60:270-275.
[15]Walenkamp GH, Vree TB, van Rens TJ. Gentamicin - PMMA beads. pharmacokinetic and nephrotoxicological study. Clin Orthop Relat Res. 1986;(205):171-183.
[16]Wei G, Kotoura Y, Oka M, et al. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis: the use of lactic acid pligomer as a carrier. J Bone Joint Surg Br. 1991; 73(2):246-252.